Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Grandview Medical Center
Birmingham, Alabama, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- St. Vincent'S Health System, Inc. D/b/a Ascension St. Vincent'S
Jacksonville, Florida, United States
- Hca Florida Mercy Hospital
Miami, Florida, United States
- St. Luke'S Boise Medical Center
Boise, Idaho, United States
- Maine Medical Center
Portland, Maine, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Lahey Hospital and Medical Center
Burlington, Massachusetts, United States
- Corewell Health William Beaumont Hospital
Royal Oak, Michigan, United States
- the Valley Hospital
Paramus, New Jersey, United States
- North Shore University Hospital, Northwell Health
Manhasset, New York, United States
- Doylestown Hospital
Doylestown, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Trident Medical Center
Charleston, South Carolina, United States
- Orion Medical
Houston, Texas, United States
- Methodist Hospital-San Antonio
San Antonio, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Oct 2024
- Primary completion
- 16 Nov 2025
- Completion
- 16 Nov 2025
- Last update posted
- 15 May 2026
- Registered enrollment
- 198
- Registry id
- NCT06364215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.